Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Debt Ratio (2018 - 2023)

X4 Pharmaceuticals (XFOR) has disclosed Debt Ratio for 5 consecutive years, with 0.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Debt Ratio fell 95.85% year-over-year to 0.0, compared with a TTM value of 0.0 through Jun 2023, down 95.85%, and an annual FY2022 reading of 0.01, up 24.57% over the prior year.
  • Debt Ratio was 0.0 for Q2 2023 at X4 Pharmaceuticals, down from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.2 in Q2 2019 and bottomed at 0.0 in Q2 2023.
  • Average Debt Ratio over 4 years is 0.06, with a median of 0.02 recorded in 2022.
  • The sharpest move saw Debt Ratio surged 2142.11% in 2022, then tumbled 95.85% in 2023.
  • Year by year, Debt Ratio stood at 0.2 in 2019, then crashed by 96.56% to 0.01 in 2021, then increased by 24.57% to 0.01 in 2022, then tumbled by 47.87% to 0.0 in 2023.
  • Business Quant data shows Debt Ratio for XFOR at 0.0 in Q2 2023, 0.0 in Q1 2023, and 0.01 in Q4 2022.